Form 4: Stepan Co. Executive Sean Thomas Moriarty Reports Stock Transactions

Sean Thomas Moriarty, VP & GM Surfactants at Stepan Co., reports acquisition and disposal of common stock and derivative securities.

Summary

• Sean Thomas Moriarty, a VP & GM at Stepan Co. (SCL), filed a Form 4 detailing changes in beneficial ownership.
• On March 4, 2025, Moriarty acquired 571 shares of common stock at $57.275 per share through the settlement of restricted stock units (RSUs).
• Also on March 4, 2025, 168 shares were disposed of to cover tax liabilities related to the vesting of RSUs, also at $57.275 per share.
• Following these transactions, Moriarty directly owns 14,376.0715 shares of common stock and indirectly owns 4,478.351 shares through an ESOP II Trust.
• Moriarty also reported the acquisition of 2,506 performance shares, 5,012 restricted stock units, and 7,075 stock appreciation rights on March 3, 2025.
• These derivative securities represent contingent rights to receive Stepan Company common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. There's no indication of unusual activity or significant concerns.

Positives

• The acquisition of performance shares, restricted stock units, and stock appreciation rights suggests confidence in the company's future performance.

Negatives

• The disposal of shares to cover tax liabilities, while routine, slightly reduces Moriarty's direct holdings.

Risks

• The value of the derivative securities is contingent on Stepan Company achieving certain performance goals and the market price of the common stock.

Future Outlook

The reporting person will continue to vest in restricted stock units over the next three years.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's sentiment and potential future performance.

Comparison to Industry Standards

• Comparing Sean Moriarty's holdings and transactions to those of executives at similar chemical companies like Dow or BASF would provide a benchmark for assessing his level of investment in Stepan Co.
• Analyzing the types of equity compensation awarded (RSUs, performance shares, stock appreciation rights) against industry norms can reveal Stepan Co.'s approach to incentivizing its executives.
• Reviewing the vesting schedules and performance metrics associated with these awards in comparison to industry peers can offer insights into the company's long-term strategic goals.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.
• Transparency through Form 4 filings helps maintain investor confidence.

Key Dates